We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of the Effectiveness of Biodentine® in Pulpotomies Primary Teeth

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01655342
First Posted: August 1, 2012
Last Update Posted: September 2, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Hadassah Medical Organization
  Purpose
Clinical and radiographic assessment of Biodentine® as a pulp dressing material for pulpotomy treatment in human primary molars.

Condition
Effectiveness of Biodentine® in Pulpotomies Primary Teeth

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Assessment of the Effectiveness of Biodentine® in Pulpotomies Primary Teeth.

Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • Success of the primary molar pulpotomy [ Time Frame: One year ]

Estimated Enrollment: 60
Study Start Date: August 2012
Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
formocresol

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   3 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Healthy children attending the Pediatric Dentistry Clinic of the Hebrew University-Hadassah School of Dental Medicine in Jerusalem
Criteria

Inclusion Criteria:

  • one or more primary teeth which requires pulpotomy.

Exclusion Criteria:

  • not healthy patients,
  • patients with teeth which requires pulpectomy.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01655342


Locations
Israel
Hadassah Medical Organization
Jerusalem, Israel
Sponsors and Collaborators
Hadassah Medical Organization
  More Information

Publications:
Responsible Party: Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01655342     History of Changes
Other Study ID Numbers: Moran- HMO-CTIL
First Submitted: July 30, 2012
First Posted: August 1, 2012
Last Update Posted: September 2, 2016
Last Verified: August 2016

Keywords provided by Hadassah Medical Organization:
pulpotomy
primary teeth
Biodentine®
formocresol